The treatment of hypertension in patients with erectile dysfunction

被引:25
|
作者
Mikhailidis, DP
Khan, MA
Milionis, HJ
Morgan, RJ
机构
[1] UCL Royal Free & Univ Coll Med Sch, Dept Mol Pathol & Clin Biochem, London NW3 2QG, England
[2] UCL Royal Free & Univ Coll Med Sch, Dept Urol, London NW3 2QG, England
关键词
beta-blockers; diuretics; doxazosin; erectile dysfunction; hypertension;
D O I
10.1185/0300799009117037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is another predictor of erectile dysfunction (ED). This is further evidence supporting a link between the pathogenesis of atherosclerotic disease ann ED. In one study (TOMHS) involving hypertensive patients, the incidence of ED was 14.4%. The drugs used to treat hypertension may cause ED. However, there is little trial-based evidence to indicate which drugs are more likely to cause this side effect. In general, thiazide diuretics and beta-blockers seem to cause ED more often. In contrast, the alpha-blocker doxazosin, has Mot been associated with an increased incidence of ED as a sine effect. Doxazosin also improves urinary flow in patients with benign prostatic hyperplasia (BPH). This condition is common in elderly men as is hypertension and ED. Therefore, doxazosin may present a special advantage among this group of patients. This alpha-blocker would also be a good choice in patients with impaired glucose tolerance/diabetes because it improves insulin sensitivity. Moreover, ED and hypertension are more prevalent among diabetics. On a more speculative note, doxazosin may potentiate the therapeutic impact of specific treatments for ED.
引用
收藏
页码:S31 / S36
页数:6
相关论文
共 50 条
  • [31] Nebivolol versus other beta blockers in patients with hypertension and erectile dysfunction
    Sharp, Randall P.
    Gales, Barry J.
    THERAPEUTIC ADVANCES IN UROLOGY, 2017, 9 (02) : 59 - 63
  • [32] Erectile dysfunction and its influence on quality of life in patients with essential hypertension
    Kushiro, T
    Takahashi, A
    Saito, F
    Otsuka, Y
    Soma, M
    Kurihara, T
    Satomura, A
    Saito, T
    Kanmatsuse, K
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (03) : 427 - 430
  • [33] Male Erectile Dysfunction and Microalbuminuria in Adult Nigerians with Essential Hypertension
    Busari, Olusegun Adesola
    Opadijo, Oladimeji George
    Olarewaju, Timothy Olusegun
    Oladosu, Yusuf Olatunji
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2013, 5 (01) : 32 - 36
  • [34] The effect of non-dipper pattern of hypertension on erectile dysfunction
    Erden, Ismail
    Ozhan, Hakan
    Ordu, Serkan
    Yalcin, Subhan
    Basar, Cengiz
    Caglar, Onur
    Kayikci, Ali
    BLOOD PRESSURE, 2010, 19 (04) : 249 - 253
  • [35] Tangeretin ameliorates erectile and testicular dysfunction in a rat model of hypertension
    Chiangsaen, Petcharat
    Maneesai, Putcharawipa
    Kukongviriyapan, Upa
    Tong-un, Terdthai
    Ishida, Wannapa
    Prachaney, Parichat
    Pakdeechote, Poungrat
    REPRODUCTIVE TOXICOLOGY, 2020, 96 : 1 - 10
  • [36] Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data
    Shabsigh, Ridwan
    Duval, Sue
    Shah, Manan
    Regan, Timothy S.
    Juhasz, Marta
    Veltry, Lauren G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) : 2453 - 2460
  • [37] The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners
    Brock, Gerald
    Chan, John
    Carrier, Serge
    Chan, Melanie
    Salgado, Luis
    Klein, Alexander H.
    Lang, Clement
    Horner, Richard
    Gutkin, Stephen
    Dickson, Ruth
    BJU INTERNATIONAL, 2007, 99 (02) : 376 - 382
  • [38] Vardenafil treatment for erectile dysfunction
    Crowe, SM
    Streetman, DS
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (01) : 77 - 85
  • [39] Tadalafil for the treatment of erectile dysfunction
    Culley C. Carson
    Current Urology Reports, 2003, 4 (6) : 455 - 456
  • [40] Shockwave treatment of erectile dysfunction
    Gruenwald, Ilan
    Appel, Boaz
    Kitrey, Noam D.
    Vardi, Yoram
    THERAPEUTIC ADVANCES IN UROLOGY, 2013, 5 (02) : 95 - 99